Effect of Early Management on PAin and DEpression in Patients With PancreatoBiliary Cancer, EPADE-PB
- Conditions
- Cancer PainPancreatic CancerBiliary Tract CancerDepression
- Interventions
- Other: Early Palliative care integrated with usual oncologic care
- Registration Number
- NCT01589328
- Lead Sponsor
- National Cancer Center, Korea
- Brief Summary
Effect of Early management on PAin and DEpression in patients with PancreatoBiliary Cancer, EPADE-PB
Purpose
To determine whether early palliative care integrated with usual oncologic care with automated symptom monitoring can improve depression and pain in patients with cancer
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 288
- Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No
- Pathologic confirmed locally advanced or metastatic pancreatic cancer or biliary tract cancer
- within 8 weeks after diagnosis
- cancer-related pain (Brief Pain Inventory [BPI] worst pain score >3), depression (Center for Epidemiological Studies-Depression Scale [CES-D] >16) or both
- Karnofsky Performance Rating Scale ≥50%
- Opioid intolerance
- History of drug or alcohol abuse
- Impaired sensory or cognitive function
- Pregnant or lactating woman
- Women of child bearing potential not using a contraceptive method
- Sexually active fertile men not using effective birth control during medication of study drug and up to 6 months after completion of study drug if their partners are women of child-bearing potential
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Early Palliative care Early Palliative care integrated with usual oncologic care The interventions consisted of the following: (1) Nursing assessment of pain and depression mood (2) Pain control based NCCN guideline (3) Depression control by psychoeducation and/or consultation of psychiatrist specialist (4) Patient education
- Primary Outcome Measures
Name Time Method Reduction in depression score at baseline, 1 month, and every 3 months, up to 1 year Reduction in depression score, Center for Epidemiological Studies-Depression Scale \[CES-D\]
Reduction in pain score at baseline, 1 month, and every 3 months, up to 1 year • Reduction in pain scores, Brief Pain Inventory \[BPI\] severity
- Secondary Outcome Measures
Name Time Method Quality of life at baseline, 1 month, and every 3 months, up to 1 year EORTC QLQ-C30 General Questionnaire, Korean version
Overall survival at baseline, 1 month, and every 3 months, up to 1 year
Trial Locations
- Locations (1)
National Cancer Center
🇰🇷Goyang, 410-769, Gyeonggi-do, Korea, Republic of